Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05228886 · ClinicalTrials.gov registry record · NA
The SINCERE Intervention to Address COVID-19 Health Disparities
A NA study of COVID-19 and Social Determinants of Health, sponsored by Andrea Wallace.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 1
- Study location
NCT05228886: Recruiting NA study of COVID-19 and Social Determinants of Health, sponsored by Andrea Wallace.
NCT05228886 is a NA study of COVID-19 and Social Determinants of Health that is actively recruiting participants, run by Andrea Wallace. The registered enrollment target is 1,500 participants, below the 38,460-participant average among 298 other COVID-19 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05228886, a NA study of COVID-19 and Social Determinants of Health, is actively recruiting participants, sponsored by Andrea Wallace.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic. With statewide community service providers, existing health information technology, and piloted methods, we seek to determine the effectiveness of universal social needs screening and community service referrals - the SINCERE intervention - in improving health outcomes of COVID-19 vulnerable and socioeconomically disadvantaged populations and whether intensive follow-up and collaborative goal-setting helps overcome barriers to community service use by patients seen in the emergency department and seeking COVID testing at community-based and mobile clinic locations.
Primary Outcome
Standardized PROMIS v1.2 Global Health. 10 questions create one outcome score. Each question is on a 1-5 scale with higher numbers indicating lower severity. The outcome variable will be PROMIS v1.2 Global Health with Time included as a variable in the model.
Conditions Studied
Interventions
- OTHER Standard of Care
- BEHAVIORAL SINCERE
- BEHAVIORAL Scheduled Follow-Up
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT05228886 shows while recruiting
NCT05228886 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 38,460-participant average among 298 other COVID-19 trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT05228886 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05228886 about?
NCT05228886 is a clinical study titled "The SINCERE Intervention to Address COVID-19 Health Disparities". The goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of the social, behavio...
What is the current status of trial NCT05228886?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2021-09-27. Estimated completion is 2026-03-31.
What conditions does trial NCT05228886 study?
This clinical trial studies the following conditions: COVID-19, Social Determinants of Health, Vulnerable Populations.
What interventions are being tested in trial NCT05228886?
The interventions under investigation include: Standard of Care (OTHER), SINCERE (BEHAVIORAL), Scheduled Follow-Up (BEHAVIORAL).
Who is sponsoring clinical trial NCT05228886?
This trial is sponsored by Andrea Wallace, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05228886 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05228886's enrollment target sits among peer trials
1,500 53rd of 298 higher than 244 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI